$CPHC
Canterbury Park Holding Corp Stock $cphc

$cphc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014129 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$16.34M	$13.30M	$13.64M
YoY Change	-8.06%	-2.48%	47.82%
Cost Of Revenue	$3.522M	$2.321M	$2.368M
YoY Change	-13.43%	-2.02%	53.8%
Gross Profit	$12.82M	$10.98M	$11.27M
YoY Change	-6.47%	-2.58%	57.18%
Gross Profit Margin	78.45%	82.55%	82.63%
Selling, General & Admin	$9.412M	$7.566M	$7.108M
YoY Change	3.82%	6.45%	41.04%
% of Gross Profit	73.42%	68.92%	63.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$741.6K	$735.3K	$745.9K
YoY Change	0.01%	-1.43%	8.17%
% of Gross Profit	5.78%	6.7%	6.62%
Operating Expenses	$11.76M	$9.425M	$8.843M
YoY Change	6.74%	6.58%	37.75%
Operating Profit	$7.552M	$1.554M	$2.426M
YoY Change	179.43%	-35.96%	90.73%
Interest Expense	-$124.9K	$2.258M	-$46.68K
YoY Change	-62.04%	-4936.53%	-90.07%
% of Operating Profit	-1.65%	145.3%	-1.92%
Other Income/Expense, Net	-$124.9K	$2.258M	-$46.68K
YoY Change	-62.05%	-4936.31%	-90.03%
Pretax Income	$7.428M	$3.812M	$2.380M
YoY Change	212.91%	60.17%	196.02%
Income Tax	$2.135M	$1.041M	$606.0K
% Of Pretax Income	28.74%	27.31%	25.46%
Net Earnings	$5.293M	$2.771M	$1.774M
YoY Change	201.56%	56.18%	221.66%
Net Earnings / Revenue	32.39%	20.83%	13.01%
Basic Earnings Per Share	$1.08	$0.57	$0.37
Diluted Earnings Per Share	$1.07	$0.56	$0.36
COMMON SHARES
Basic Shares Outstanding	4.910M	4.897M	4.818M
Diluted Shares Outstanding	4.931M	4.923M	4.864M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.05M	$21.73M	$13.22M
YoY Change	98.24%	64.43%	482.25%
Cash & Equivalents	$24.05M	$16.73M	$13.22M
Short-Term Investments	$5.000M	$5.000M
Other Short-Term Assets	$6.253M	$6.747M	$10.61M
YoY Change	-60.86%	-36.44%	132.26%
Inventory	$405.5K	$268.4K	$249.0K
Prepaid Expenses	$632.1K	$620.7K	$659.4K
Receivables	$1.769M	$963.4K	$625.8K
Other Receivables	$1.180M	$1.738M	$1.476M
Total Short-Term Assets	$38.65M	$31.45M	$26.18M
YoY Change	3.52%	20.12%	139.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.00M	$37.01M	$34.45M
YoY Change	12.83%	7.42%	4.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.814M	$6.840M	$7.005M
YoY Change	-3.01%	-2.36%	1.86%
Other Assets	$18.03K	$48.03K	$87.85K
YoY Change	-77.34%	-45.33%	-32.42%
Total Long-Term Assets	$63.51M	$62.30M	$59.60M
YoY Change	7.45%	4.54%	2.09%
TOTAL ASSETS
Total Short-Term Assets	$38.65M	$31.45M	$26.18M
Total Long-Term Assets	$63.51M	$62.30M	$59.60M
Total Assets	$102.2M	$93.75M	$85.78M
YoY Change	5.93%	9.29%	23.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.386M	$2.095M	$2.663M
YoY Change	-17.82%	-21.33%	37.47%
Accrued Expenses	$2.241M	$2.965M	$3.056M
YoY Change	-10.32%	-2.97%	5.76%
Deferred Revenue	$975.9K	$846.8K	$945.7K
YoY Change	-28.09%	-10.46%	95.73%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.930K	$11.99K	$27.40K
YoY Change	-82.23%	-56.24%	-8.67%
Total Short-Term Liabilities	$12.85M	$10.47M	$10.88M
YoY Change	-33.47%	-3.71%	10.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$11.99K
YoY Change	-100.0%	-100.0%	-70.03%
Other Long-Term Liabilities	$1.943M	$1.304M	$1.720M
YoY Change	-12.35%	-24.18%	8500.8%
Total Long-Term Liabilities	$10.14M	$9.505M	$9.403M
YoY Change	2.54%	1.09%	26.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.85M	$10.47M	$10.88M
Total Long-Term Liabilities	$10.14M	$9.505M	$9.403M
Total Liabilities	$22.99M	$19.98M	$20.28M
YoY Change	-21.27%	-1.48%	17.54%
SHAREHOLDERS EQUITY
Retained Earnings	$52.59M	$47.64M	$40.51M
YoY Change	25.44%	17.61%	43.83%
Common Stock	$26.59M	$26.13M	$24.99M
YoY Change	4.99%	4.56%	4.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.17M	$73.78M	$65.50M
YoY Change
Total Liabilities & Shareholders Equity	$102.2M	$93.75M	$85.78M
YoY Change	5.93%	9.3%	23.76%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$5.293M	$2.771M	$1.774M
YoY Change	201.56%	56.18%	221.66%
Depreciation, Depletion And Amortization	$741.6K	$735.3K	$745.9K
YoY Change	0.01%	-1.43%	8.17%
Cash From Operating Activities	$4.978M	$5.822M	$2.937M
YoY Change	-32.28%	98.26%	73.42%
INVESTING ACTIVITIES
Capital Expenditures	$3.582M	$1.010M	-$778.0K
YoY Change	-483.92%	-229.85%	-701.96%
Acquisitions
YoY Change
Other Investing Activities	$8.184M	-$45.86K	-$345.6K
YoY Change	717.39%	-86.73%	-531.98%
Cash From Investing Activities	$4.602M	-$1.056M	-$1.124M
YoY Change	6637.3%	-6.0%	1965.94%
FINANCING ACTIVITIES
Cash Dividend Paid		$345.4K	$336.2K
YoY Change		2.75%	67956.28%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-267.1K	-$519.1K	-$554.7K
YoY Change	-3.81%	-6.42%	-3602.32%
NET CHANGE
Cash From Operating Activities	4.978M	$5.822M	$2.937M
Cash From Investing Activities	4.602M	-$1.056M	-$1.124M
Cash From Financing Activities	-267.1K	-$519.1K	-$554.7K
Net Change In Cash	9.313M	$4.247M	$1.258M
YoY Change	30.4%	237.48%	-23.95%
FREE CASH FLOW
Cash From Operating Activities	$4.978M	$5.822M	$2.937M
Capital Expenditures	$3.582M	$1.010M	-$778.0K
Free Cash Flow	$1.396M	$4.812M	$3.715M
YoY Change	-83.15%	29.54%	137.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19250	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19250	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4910408
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4910408
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4888975
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4888975
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2022Q4	cphc	Investee Losses In Excess Of Equity Investment InvesteeLossesInExcessOfEquityInvestment	3185923	usd
CY2023Q1	cphc	Income Loss From Equity Method Investments Gross IncomeLossFromEquityMethodInvestmentsGross	-23232	usd
CY2023Q1	cphc	Investee Losses In Excess Of Equity Investment InvesteeLossesInExcessOfEquityInvestment	1304179	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37858
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5349765
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1100 Canterbury Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Shakopee
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55379
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock Common stock, $.01 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	CPHC
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4910408
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16732959	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12989087	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3620234	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3116916	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	5000000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5000000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	963371	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	618365	usd
CY2023Q1	cphc	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2505601	usd
CY2022Q4	cphc	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	6103236	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	268350	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	262073	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	620665	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	557520	usd
CY2023Q1	cphc	Income Taxes Receivable And Prepaid Income Taxes Current IncomeTaxesReceivableAndPrepaidIncomeTaxesCurrent	1738364	usd
CY2022Q4	cphc	Income Taxes Receivable And Prepaid Income Taxes Current IncomeTaxesReceivableAndPrepaidIncomeTaxesCurrent	2052364	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	31449544	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30699561	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	27000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	27000	usd
CY2023Q1	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	21034	usd
CY2022Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	41774	usd
CY2023Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	13499248	usd
CY2022Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	13294337	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	6840285	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	6863517	usd
CY2023Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	2303010	usd
CY2022Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	2303010	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37011180	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36491660	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	62302933	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	61576618	usd
CY2023Q1	us-gaap	Assets Assets	93752477	usd
CY2022Q4	us-gaap	Assets Assets	92276179	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2094734	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3368683	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2964798	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2684444	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2036595	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1814879	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	346052	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	341602	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	993234	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	795646	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	846795	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	413442	usd
CY2023Q1	cphc	Accounts Payable To Horsepersons AccountsPayableToHorsepersons	1177828	usd
CY2022Q4	cphc	Accounts Payable To Horsepersons AccountsPayableToHorsepersons	993529	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	11994	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18973	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10472031	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10431198	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8201015	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7474015	usd
CY2023Q1	cphc	Investee Losses In Excess Of Equity Investment InvesteeLossesInExcessOfEquityInvestment	1304179	usd
CY2022Q4	cphc	Investee Losses In Excess Of Equity Investment InvesteeLossesInExcessOfEquityInvestment	3185923	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9505194	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10659938	usd
CY2023Q1	us-gaap	Liabilities Liabilities	19977225	usd
CY2022Q4	us-gaap	Liabilities Liabilities	21091136	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	49104	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	48890	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26084008	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	25914644	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47642140	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	45221509	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	73775252	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	71185043	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93752477	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92276179	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13299558	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13637972	usd
CY2023Q1	cphc	Purse Expense PurseExpense	1334973	usd
CY2022Q1	cphc	Purse Expense PurseExpense	1437641	usd
CY2023Q1	cphc	Minnesota Breeders Fund MinnesotaBreedersFund	210905	usd
CY2022Q1	cphc	Minnesota Breeders Fund MinnesotaBreedersFund	229057	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5874805	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5507957	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	735261	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	745949	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	298507	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	301432	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1004228	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	940479	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1123549	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	989086	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	11745737	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	11211736	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1553821	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2426236	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1858512	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-239522	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	399175	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	192840	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2257687	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46682	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3811508	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2379554	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1041000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	605641	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2770508	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1773913	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4893324
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4818339
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4923132
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4864247
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	71185043	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	129477	usd
CY2023Q1	us-gaap	Dividends Dividends	349877	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	206806	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-166705	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2770508	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	73775252	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	64353226	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	104927	usd
CY2022Q1	us-gaap	Dividends Dividends	675872	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	156710	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-211859	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1773913	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	65501045	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2770508	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1773913	usd
CY2023Q1	us-gaap	Depreciation Depreciation	735261	usd
CY2022Q1	us-gaap	Depreciation Depreciation	745949	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	129477	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	104927	usd
CY2023Q1	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	206806	usd
CY2022Q1	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	156710	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	727000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1858512	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-239522	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	345006	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	237486	usd
CY2023Q1	cphc	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable	-3597635	usd
CY2022Q1	cphc	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable	-0	usd
CY2023Q1	cphc	Increase Decrease In Tif Receivable IncreaseDecreaseInTIFReceivable	204911	usd
CY2022Q1	cphc	Increase Decrease In Tif Receivable IncreaseDecreaseInTIFReceivable	165266	usd
CY2023Q1	cphc	Increase Decrease In Inventories And Prepaid Expense IncreaseDecreaseInInventoriesAndPrepaidExpense	48682	usd
CY2022Q1	cphc	Increase Decrease In Inventories And Prepaid Expense IncreaseDecreaseInInventoriesAndPrepaidExpense	70963	usd
CY2023Q1	cphc	Increase Decrease In Income Taxes Payable And Prepaid Income Taxes IncreaseDecreaseInIncomeTaxesPayableAndPrepaidIncomeTaxes	-314000	usd
CY2022Q1	cphc	Increase Decrease In Income Taxes Payable And Prepaid Income Taxes IncreaseDecreaseInIncomeTaxesPayableAndPrepaidIncomeTaxes	212228	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1518416	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	237324	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	433353	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	212386	usd
CY2023Q1	cphc	Increase Decrease In Card Casino Accruals IncreaseDecreaseInCardCasinoAccruals	280355	usd
CY2022Q1	cphc	Increase Decrease In Card Casino Accruals IncreaseDecreaseInCardCasinoAccruals	-201651	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	221716	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5249	usd
CY2023Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	197588	usd
CY2022Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	202168	usd
CY2023Q1	cphc	Increase Decrease In Accounts Payable To Horsepersons IncreaseDecreaseInAccountsPayableToHorsepersons	184299	usd
CY2022Q1	cphc	Increase Decrease In Accounts Payable To Horsepersons IncreaseDecreaseInAccountsPayableToHorsepersons	146264	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5822471	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2936818	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1010314	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	778041	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	340026	usd
CY2023Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	45856	usd
CY2022Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	5554	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1056170	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1123621	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	345427	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	336198	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	166705	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	211859	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6979	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6641	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-519111	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-554698	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4247190	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1258499	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16106003	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15598753	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20353193	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16857252	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	244000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	119000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	346000	usd
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	340000	usd
CY2023Q1	cphc	Change In Investee Losses In Excess Of Equity Investments ChangeInInvesteeLossesInExcessOfEquityInvestments	-1882000	usd
CY2022Q1	cphc	Change In Investee Losses In Excess Of Equity Investments ChangeInInvesteeLossesInExcessOfEquityInvestments	515000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	818000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2023Q1	cphc	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2505601	usd
CY2022Q4	cphc	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	6103236	usd
CY2021Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6103236	usd
CY2023Q1	cphc	Funds Due To Organization FundsDueToOrganization	1234000	usd
CY2022Q1	cphc	Funds Due To Organization FundsDueToOrganization	1298000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2770508	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1773913	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4893324
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4818339
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29808
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45907
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4923132
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4864247
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2023Q1	cphc	Source Of Revenues Of Horse Racing Segment SourceOfRevenuesOfHorseRacingSegment	0.25	pure
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1041000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13300000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13638000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3812000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2380000	usd
CY2023Q1	us-gaap	Assets Assets	93752000	usd
CY2022Q4	us-gaap	Assets Assets	92276000	usd
CY2022Q4	cphc	Obligation By Third Party Per Agreement Due Remainder Of Fiscal Year ObligationByThirdPartyPerAgreementDueRemainderOfFiscalYear	7380000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	6863517	usd
CY2022Q4	cphc	Equity Method Investments Net EquityMethodInvestmentsNet	3677594	usd
CY2023Q1	cphc	Investee Losses In Excess Of Equity Investment During Period InvesteeLossesInExcessOfEquityInvestmentDuringPeriod	1881744	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1858512	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	6840285	usd
CY2023Q1	cphc	Equity Method Investments Net EquityMethodInvestmentsNet	5536106	usd
CY2021Q4	cphc	Tif Improvement Costs TIFImprovementCosts	23336500	usd
CY2022Q1	cphc	Estimated Cost Of Tax Increment Financing Eligible Improvements Expected Reduction EstimatedCostOfTaxIncrementFinancingEligibleImprovementsExpectedReduction	5744000	usd
CY2022Q1	cphc	Estimated Cost Of Tax Increment Financing Eligible Improvements Maximum EstimatedCostOfTaxIncrementFinancingEligibleImprovementsMaximum	17592881	usd
CY2022Q1	cphc	Estimated Cost Of Tax Increment Financing Eligible Improvements Maximum EstimatedCostOfTaxIncrementFinancingEligibleImprovementsMaximum	17592881	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	110309	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	108639	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6715	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6471	usd
CY2023Q1	cphc	Operating And Finance Lease Rightofuse Asset OperatingAndFinanceLeaseRightofuseAsset	11994	usd
CY2022Q4	cphc	Operating And Finance Lease Rightofuse Asset OperatingAndFinanceLeaseRightofuseAsset	18973	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	113565	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	106586	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M12D
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	12146	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	12146	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	152	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	11994	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	11994	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-014129-index-headers.html	Edgar Link	pending
0001437749-23-014129-index.html	Edgar Link	pending
0001437749-23-014129.txt	Edgar Link	pending
0001437749-23-014129-xbrl.zip	Edgar Link	pending
cphc-20230331.xsd	Edgar Link	pending
cphc20230331_10q.htm	Edgar Link	pending
ex_468554.htm	Edgar Link	pending
ex_468555.htm	Edgar Link	pending
ex_468556.htm	Edgar Link	pending
ex_468557.htm	Edgar Link	pending
ex_468557img001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
cphc-20230331_cal.xml	Edgar Link	unprocessable
cphc-20230331_lab.xml	Edgar Link	unprocessable
cphc-20230331_def.xml	Edgar Link	unprocessable
cphc-20230331_pre.xml	Edgar Link	unprocessable
cphc20230331_10q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPHC
Canterbury Park Holding Corp Stock $cphc

2023 Q2 Form 10-Q Financial Statement

#000143774923014129 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPHC Canterbury Park Holding Corp Stock $cphc

2023 Q2 Form 10-Q Financial Statement

#000143774923014129 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPHC
Canterbury Park Holding Corp Stock $cphc